More than 15.6 million children across Kenya have received life-saving vaccines against measles, rubella, and typhoid as the national immunisation campaign enters its final phase.
Health Cabinet Secretary Aden Duale announced that, since the campaign began on July 5, an impressive 3.5 million children have received the measles-rubella vaccine, while 12.1 million have been vaccinated against typhoid using the Typhoid Conjugate Vaccine (TCV). The campaign targets 6.5 million and 19.2 million children for the two vaccines, respectively.
Duale also highlighted a significant milestone: over 4,000 “zero-dose” children—those who had never been vaccinated before—have now received both vaccines.
“With only three days remaining in the main campaign and two additional mop-up days, we are urging all parents and caregivers to take action now,” Duale said in a statement on Saturday. “Vaccination is safe, effective, and critical in saving children’s lives.”
The vaccines, which are approved by the World Health Organization (WHO), are being offered free of charge at public health facilities and designated outreach centres including schools, churches, mosques, markets, and community hubs. To ensure no child is left out, the Ministry of Health has deployed mobile vaccination teams to reach remote and underserved communities.
The campaign underscores the government’s commitment to preventing childhood deaths from vaccine-preventable diseases. Duale reaffirmed that no child should die due to lack of access to vaccines.
“We urge all Kenyans to seek accurate information from trusted sources such as the Ministry of Health, health professionals, and accredited partners,” Duale added. “Misinformation puts lives at risk.”
As the campaign nears its conclusion, the Ministry is calling on the public to make use of the remaining days to protect their children from these potentially deadly diseases. The national immunisation drive represents a major step forward in safeguarding Kenya’s future generations through accessible and equitable healthcare.